Johnson & Johnson (JNJ) Gets a Buy from RBC Capital
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) on January 6 and set a price ...
J&J's Posdinemab Granted FDA Fast Track Designation For Alzheimer's Treatment
Johnson & Johnson (JNJ) announced that the FDA has granted Fast Track designation to its Posdinema, a monoclonal antibody ...
Gehost op MSN28d
Why Johnson & Johnson (JNJ)’s Legal Issues Could Wrap Up Quickly
The progress on the lawsuit is likely to be decided in January 2025 when a Houston judge will decide whether to approve JNJ’s latest offer. Johnson & Johnson (J&J), formed in 1886, is a ...